288 related articles for article (PubMed ID: 34489308)
1. STAT3-mediated upregulation of the AIM2 DNA sensor links innate immunity with cell migration to promote epithelial tumourigenesis.
Dawson RE; Deswaerte V; West AC; Tang K; West AJ; Balic JJ; Gearing LJ; Saad MI; Yu L; Wu Y; Bhathal PS; Kumar B; Chakrabarti JT; Zavros Y; Oshima H; Klinman DM; Oshima M; Tan P; Jenkins BJ
Gut; 2022 Aug; 71(8):1515-1531. PubMed ID: 34489308
[TBL] [Abstract][Full Text] [Related]
2. Cross-talk between IL-6 trans-signaling and AIM2 inflammasome/IL-1β axes bridge innate immunity and epithelial apoptosis to promote emphysema.
Ruwanpura SM; McLeod L; Dousha LF; Seow HJ; West AC; West AJ; Weng T; Alanazi M; MacDonald M; King PT; Bardin PG; Gabay C; Klinman DM; Bozinovski S; Vlahos R; Anderson GP; Rose-John S; Saad MI; Jenkins BJ
Proc Natl Acad Sci U S A; 2022 Sep; 119(36):e2201494119. PubMed ID: 36037355
[TBL] [Abstract][Full Text] [Related]
3. The cytosolic DNA sensor AIM2 promotes Helicobacter-induced gastric pathology via the inflammasome.
Dawson RE; Deswaerte V; West AC; Sun E; Wray-McCann G; Livis T; Kumar B; Rodriguez E; Gabay C; Ferrero RL; Jenkins BJ
Immunol Cell Biol; 2023 May; 101(5):444-457. PubMed ID: 36967659
[TBL] [Abstract][Full Text] [Related]
4. Hyperactive gp130/STAT3-driven gastric tumourigenesis promotes submucosal tertiary lymphoid structure development.
Hill DG; Yu L; Gao H; Balic JJ; West A; Oshima H; McLeod L; Oshima M; Gallimore A; D'Costa K; Bhathal PS; Sievert W; Ferrero RL; Jenkins BJ; Jones GW
Int J Cancer; 2018 Jul; 143(1):167-178. PubMed ID: 29417587
[TBL] [Abstract][Full Text] [Related]
5. The AIM2 inflammasome is a central regulator of intestinal homeostasis through the IL-18/IL-22/STAT3 pathway.
Ratsimandresy RA; Indramohan M; Dorfleutner A; Stehlik C
Cell Mol Immunol; 2017 Jan; 14(1):127-142. PubMed ID: 27524110
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-11-driven gastric tumourigenesis is independent of trans-signalling.
Balic JJ; Garbers C; Rose-John S; Yu L; Jenkins BJ
Cytokine; 2017 Apr; 92():118-123. PubMed ID: 28160627
[TBL] [Abstract][Full Text] [Related]
7. Cytosolic DNA sensor AIM2 promotes KRAS-driven lung cancer independent of inflammasomes.
Alanazi M; Weng T; McLeod L; Gearing LJ; Smith JA; Kumar B; Saad MI; Jenkins BJ
Cancer Sci; 2024 Apr; ():. PubMed ID: 38594840
[TBL] [Abstract][Full Text] [Related]
8. Serine-Phosphorylated STAT3 Promotes Tumorigenesis via Modulation of RNA Polymerase Transcriptional Activity.
Balic JJ; Garama DJ; Saad MI; Yu L; West AC; West AJ; Livis T; Bhathal PS; Gough DJ; Jenkins BJ
Cancer Res; 2019 Oct; 79(20):5272-5287. PubMed ID: 31481496
[TBL] [Abstract][Full Text] [Related]
9. Absent in melanoma 2 suppresses epithelial-mesenchymal transition via Akt and inflammasome pathways in human colorectal cancer cells.
Yang Y; Zhang M; Jin C; Ding Y; Yang M; Wang R; Zhou Y; Zhou Y; Li T; Wang K; Hu R
J Cell Biochem; 2019 Oct; 120(10):17744-17756. PubMed ID: 31210372
[TBL] [Abstract][Full Text] [Related]
10. AIM2 Inflammasome's First Decade of Discovery: Focus on Oral Diseases.
Wang L; Sun L; Byrd KM; Ko CC; Zhao Z; Fang J
Front Immunol; 2020; 11():1487. PubMed ID: 32903550
[TBL] [Abstract][Full Text] [Related]
11. Differential role of MyD88 and Mal/TIRAP in TLR2-mediated gastric tumourigenesis.
Kennedy CL; Najdovska M; Tye H; McLeod L; Yu L; Jarnicki A; Bhathal PS; Putoczki T; Ernst M; Jenkins BJ
Oncogene; 2014 May; 33(19):2540-6. PubMed ID: 23728346
[TBL] [Abstract][Full Text] [Related]
12. AIM2 inflammasome in infection, cancer, and autoimmunity: Role in DNA sensing, inflammation, and innate immunity.
Man SM; Karki R; Kanneganti TD
Eur J Immunol; 2016 Feb; 46(2):269-80. PubMed ID: 26626159
[TBL] [Abstract][Full Text] [Related]
13. CCL19 suppresses gastric cancer cell proliferation, migration, and invasion through the CCL19/CCR7/AIM2 pathway.
Zhou R; Sun J; He C; Huang C; Yu H
Hum Cell; 2020 Oct; 33(4):1120-1132. PubMed ID: 32564199
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of IL-11 promotes premalignant gastric epithelial hyperplasia in isolation from germline gp130-JAK-STAT driver mutations.
Buzzelli JN; O'Connor L; Scurr M; Chung Nien Chin S; Catubig A; Ng GZ; Oshima M; Oshima H; Giraud AS; Sutton P; Judd LM; Menheniott TR
Am J Physiol Gastrointest Liver Physiol; 2019 Feb; 316(2):G251-G262. PubMed ID: 30520693
[TBL] [Abstract][Full Text] [Related]
15. Inflammasome Adaptor ASC Suppresses Apoptosis of Gastric Cancer Cells by an IL18-Mediated Inflammation-Independent Mechanism.
Deswaerte V; Nguyen P; West A; Browning AF; Yu L; Ruwanpura SM; Balic J; Livis T; Girard C; Preaudet A; Oshima H; Fung KY; Tye H; Najdovska M; Ernst M; Oshima M; Gabay C; Putoczki T; Jenkins BJ
Cancer Res; 2018 Mar; 78(5):1293-1307. PubMed ID: 29282220
[TBL] [Abstract][Full Text] [Related]
16. Differential involvement of gp130 signalling pathways in modulating tobacco carcinogen-induced lung tumourigenesis.
Miller A; Brooks GD; McLeod L; Ruwanpura S; Jenkins BJ
Oncogene; 2015 Mar; 34(12):1510-9. PubMed ID: 24727895
[TBL] [Abstract][Full Text] [Related]
17. The microtubule-associated protein EB1 links AIM2 inflammasomes with autophagy-dependent secretion.
Wang LJ; Huang HY; Huang MP; Liou W; Chang YT; Wu CC; Ojcius DM; Chang YS
J Biol Chem; 2014 Oct; 289(42):29322-33. PubMed ID: 25164813
[TBL] [Abstract][Full Text] [Related]
18. AIM2 Promotes Gastric Cancer Cell Proliferation via the MAPK Signaling Pathway.
Feng X; Song Z; Huang Q; Jia J; Zhang L; Zhu M; Qian J
J Healthc Eng; 2022; 2022():8756844. PubMed ID: 35432843
[TBL] [Abstract][Full Text] [Related]
19. The DNA Sensor AIM2 Maintains Intestinal Homeostasis via Regulation of Epithelial Antimicrobial Host Defense.
Hu S; Peng L; Kwak YT; Tekippe EM; Pasare C; Malter JS; Hooper LV; Zaki MH
Cell Rep; 2015 Dec; 13(9):1922-36. PubMed ID: 26655906
[TBL] [Abstract][Full Text] [Related]
20. Strong Upregulation of AIM2 and IFI16 Inflammasomes in the Mucosa of Patients with Active Inflammatory Bowel Disease.
Vanhove W; Peeters PM; Staelens D; Schraenen A; Van der Goten J; Cleynen I; De Schepper S; Van Lommel L; Reynaert NL; Schuit F; Van Assche G; Ferrante M; De Hertogh G; Wouters EF; Rutgeerts P; Vermeire S; Nys K; Arijs I
Inflamm Bowel Dis; 2015 Nov; 21(11):2673-82. PubMed ID: 26313692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
